Unknown PHASE3 INTERVENTIONAL 2-arm NCT04341831

Does Teicoplanin Powder Use In Lumbar Instrumentation Surgery Reduce Surgical Site Infection

Sponsor: Bezmialem Vakif University

Conditions Lumbar Disc Herniation Lumbar Disc Lesion Lumbar Spinal Stenosis Lumbar Spondylolisthesis Scoliosis Lumbar Region

Interventions Teicoplanin

Updated 5 times since 2020 Last updated: Apr 10, 2020 Started: Apr 15, 2020 Primary completion: Jan 15, 2021 Completion: Apr 15, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Lumbar Disc Herniation and Lumbar Disc Lesion and is currently ongoing. Bezmialem Vakif University leads this study, which shows 5 recorded versions since 2020 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
May 2022 — Jul 2024 [monthly]

Unknown Status PHASE3

Status: Not Yet Recruiting → Unknown Status
Jan 2021 — May 2022 [monthly]

Not Yet Recruiting PHASE3
May 2020 — Jan 2021 [monthly]

Not Yet Recruiting PHASE3

First recorded

Apr 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bezmialem Vakif University

Data source: Bezmialem Vakif University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.